Growth Metrics

Nu-Med Plus (NUMD) Assets (2011 - 2025)

Nu-Med Plus recorded quarterly Assets of $7911.0 in Q4 2025, up 56.72% quarter-over-quarter from $5048.0 in Q3 2025, and down 15.6% year-over-year from $9373.0 in Q4 2024.

Nu-Med Plus' Assets history runs 15 years deep, the most recent figure standing at $7911.0 for Q4 2025.

  • In Q4 2025, Assets fell 15.6% year-over-year to $7911.0; the TTM figure through Dec 2025 stood at $7911.0 (down 15.6% YoY), while the FY2025 annual figure was $7911.0, down 15.6% from the prior year.
  • Assets came in at $7911.0 for Q4 2025 at Nu-Med Plus, up from $5048.0 in the prior quarter.
  • In the past five years, Assets ranged from a high of $285013.0 in Q1 2021 to a low of $3168.0 in Q3 2022.
  • A 5-year average of $36600.4 and a median of $10207.0 in 2024 frame the typical range for Assets.
  • Across the five-year window, Assets plunged 97.22% in 2022 and soared 645.26% in 2023, its largest moves.
  • Nu-Med Plus' Assets stood at $22163.0 in 2021, then surged by 258.91% to $79545.0 in 2022, then slumped by 83.08% to $13456.0 in 2023, then slumped by 30.34% to $9373.0 in 2024, then slipped by 15.6% to $7911.0 in 2025.
  • According to Business Quant data, Assets over the past three periods registered $7911.0, $5048.0, and $8163.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Nu-Med Plus - - - 7,911.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7,911.00
Sep 30, 2025 5,048.00
Jun 30, 2025 8,163.00
Mar 31, 2025 5,173.00
Dec 31, 2024 9,373.00
Sep 30, 2024 6,841.00
Jun 30, 2024 11,041.00
Mar 31, 2024 9,016.00
Dec 31, 2023 13,456.00
Sep 30, 2023 13,748.00
Jun 30, 2023 36,547.00
Mar 31, 2023 59,069.00
Dec 31, 2022 79,545.00
Sep 30, 2022 3,168.00
Jun 30, 2022 8,440.00
Mar 31, 2022 7,926.00
Dec 31, 2021 22,163.00
Sep 30, 2021 51,236.00
Jun 30, 2021 89,130.00
Mar 31, 2021 285,013.00
Dec 31, 2020 557,135.00
Sep 30, 2020 649,561.00
Jun 30, 2020 852,238.00
Mar 31, 2020 47,219.00
Dec 31, 2019 45,779.00
Sep 30, 2019 83,667.00
Jun 30, 2019 52,785.00
Mar 31, 2019 154,501.00
Dec 31, 2018 423,016.00
Sep 30, 2018 552,451.00
Jun 30, 2018 336,712.00
Mar 31, 2018 325,011.00
Dec 31, 2017 406,719.00
Sep 30, 2017 459,408.00
Jun 30, 2017 317,219.00
Mar 31, 2017 349,748.00
Dec 31, 2016 35,533.00
Sep 30, 2016 252,882.00
Jun 30, 2016 945,162.00
Mar 31, 2016 127,179.00
Dec 31, 2015 75,945.00
Sep 30, 2015 62,721.00
Jun 30, 2015 90,821.00
Mar 31, 2015 100,630.00
Dec 31, 2014 213,062.00
Sep 30, 2014 213,062.00
Jun 30, 2014 543,529.00
Mar 31, 2014 501,517.00
Dec 31, 2013 96,022.00
Sep 30, 2013 66,631.00
Jun 30, 2013 69,795.00
Mar 31, 2013 70,146.00
Dec 31, 2012 110,403.00
Dec 31, 2011 1,406.00